The place for remdesivir in COVID-19 treatment.

Young, Barnaby; Tan, Thuan Tong; Leo, Yee Sin

Young, Barnaby; Tan, Thuan Tong; Leo, Yee Sin.

Young B; National Centre for Infectious Diseases, Singapore 308442, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Electronic address: barnaby_young@ncid.sg.
Tan TT; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore.
Leo YS; National Centre for Infectious Diseases, Singapore 308442, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.

Lancet Infect Dis ; 21(1): 20-21, 2021 01.

Article in English | MEDLINE | ID: covidwho-1059345

Subject(s)

COVID-19 Drug Treatment; Adenosine Monophosphate/analogs & derivatives; Adult; Alanine/analogs & derivatives; Double-Blind Method; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Randomized controlled trials Limits: Adult / Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google